2012 VAM Pro/Con Debate 3521: Peanut Oral Immunotherapy is Ready for Use in Clinical Practice
Virtual Annual Meeting Recording
Pro/Con Debate 3521: Peanut Oral Immunotherapy is Ready for Use in Clinical Practice
CE Units: 1.20
CME Credits: 1.00
Upon completion of this session, participants will be able to: Outline the evidence base for oral immunotherapy with peanut; Describe the risks and benefits of OIT; Describe the current recommendations for and against clinical use of peanut OIT.
- 1.00 AttendanceAttendance credit.
- 1.20 CECE credit.
- 1.00 CMECME credit.